|
Wang, Shuhui; Breskovska, Iva; Gandhy, Shreya et al. (2018) Advances in autoimmune myasthenia gravis management. Expert Rev Neurother 18:573-588
|
|
Losen, Mario; Martinez-Martinez, Pilar; Molenaar, Peter C et al. (2015) Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs. Exp Neurol 270:18-28
|
|
Rostedt Punga, Anna; Kaminski, Henry J; Richman, David P et al. (2015) How clinical trials of myasthenia gravis can inform pre-clinical drug development. Exp Neurol 270:78-81
|
|
Kusner, Linda L; Losen, Mario; Vincent, Angela et al. (2015) Guidelines for pre-clinical assessment of the acetylcholine receptor--specific passive transfer myasthenia gravis model-Recommendations for methods and experimental designs. Exp Neurol 270:3-10
|
|
Zhou, Yuefang; Kaminski, Henry J; Gong, Bendi et al. (2014) RNA expression analysis of passive transfer myasthenia supports extraocular muscle as a unique immunological environment. Invest Ophthalmol Vis Sci 55:4348-59
|
|
Kusner, Linda L; Satija, Namita; Cheng, Georgiana et al. (2014) Targeting therapy to the neuromuscular junction: proof of concept. Muscle Nerve 49:749-56
|
|
Kusner, Linda L; Halperin, Jose A; Kaminski, Henry J (2013) Cell surface complement regulators moderate experimental myasthenia gravis pathology. Muscle Nerve 47:33-40
|
|
Benatar, Michael; Sanders, Donald B; Burns, Ted M et al. (2012) Recommendations for myasthenia gravis clinical trials. Muscle Nerve 45:909-17
|
|
Song, Chen; Xu, Zhikai; Miao, Jianting et al. (2012) Protective effect of scFv-DAF fusion protein on the complement attack to acetylcholine receptor: a possible option for treatment of myasthenia gravis. Muscle Nerve 45:668-675
|
|
Kusner, Linda L; Kaminski, Henry J (2012) The role of complement in experimental autoimmune myasthenia gravis. Ann N Y Acad Sci 1274:127-32
|
Showing the most recent 10 out of 23 publications
